Campbell & CO Investment Adviser LLC Avid Bioservices, Inc. Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$13.48 - $18.79 $135,110 - $188,332	10,023 New	10,023 $188,000
Q3 2022 Nov 14, 2022	SELL	$15.33 - $20.36 $44,119 - $58,596	-2,878 Reduced 20.49%	11,167 $214,000
Q2 2022 Aug 09, 2022	SELL	$11.63 - $21.55 $43,089 - $79,842	-3,705 Reduced 20.87%	14,045 $214,000
Q1 2022 May 09, 2022	SELL	$16.63 - $27.73 $47,395 - $79,030	-2,850 Reduced 13.83%	17,750 $362,000
Q4 2021 Feb 10, 2022	BUY	$20.7 - $34.18 $134,550 - $222,170	6,500 Added 46.1%	20,600 $601,000
Q3 2021 Nov 10, 2021	SELL	$19.05 - $28.32 $150,495 - $223,728	-7,900 Reduced 35.91%	14,100 $304,000
Q2 2021 Aug 11, 2021	BUY	$18.93 - $25.65 $416,460 - $564,300	22,000 New	22,000 $564,000

187

69.3M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $772M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.